AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-83 |
Results: 76-83/83

Authors: XU XC RO JY LEE JS SHIN DM HONG WK LOTAN R
Citation: Xc. Xu et al., DIFFERENTIAL EXPRESSION OF NUCLEAR RETINOID RECEPTORS IN NORMAL, PREMALIGNANT, AND MALIGNANT HEAD AND NECK TISSUES, Cancer research, 54(13), 1994, pp. 3580-3587

Authors: LIPPMAN SM GLISSON BS KAVANAGH JJ LOTAN R HONG WK PAREDESESPINOZA M HITTELMAN WN HOLDENER EE KRAKOFF IH
Citation: Sm. Lippman et al., RETINOIC ACID AND INTERFERON COMBINATION STUDIES IN HUMAN CANCER, European journal of cancer, 29A, 1993, pp. 9-13

Authors: LOTAN R
Citation: R. Lotan, INTERMEDIATE BIOMARKERS, Journal of cellular biochemistry, 1993, pp. 165-166

Authors: LOTAN R
Citation: R. Lotan, SQUAMOUS-CELL DIFFERENTIATION MARKERS IN NORMAL, PREMALIGNANT, AND MALIGNANT EPITHELIUM - EFFECTS OF RETINOIDS, Journal of cellular biochemistry, 1993, pp. 167-174

Authors: LOTAN R ELLERHORST J GILLENWATER A AMOS B LOTAN D OHANNESIAN D
Citation: R. Lotan et al., EXPRESSION OF LACTOSIDE-BINDING LECTINS AND THEIR COGNATE GLYCOCONJUGATES DURING INDUCED-DIFFERENTIATION OF CANCER-CELLS, Glycoconjugate journal, 10(4), 1993, pp. 246-246

Authors: DHINGRA K PAPADOPOULOS N LIPPMAN S LOTAN R LEGHA SS
Citation: K. Dhingra et al., PHASE-II STUDY OF ALPHA-INTERFERON AND 13-CIS-RETINOIC ACID IN METASTATIC MELANOMA, Investigational new drugs, 11(1), 1993, pp. 39-43

Authors: BORDEN EC LOTAN R LEVENS D YOUNG CW
Citation: Ec. Borden et al., DIFFERENTIATION THERAPY OF CANCER - LABORATORY AND CLINICAL INVESTIGATIONS, Cancer research, 53(17), 1993, pp. 4109-4115

Authors: FELZEN B LOTAN R BINAH O
Citation: B. Felzen et al., ROLE OF THYROID STATE IN AGE-DEPENDENT CARDIAC EFFECTS OF OUABAIN IN GUINEA-PIGS, Developmental pharmacology and therapeutics, 17(1-2), 1991, pp. 88-94
Risultati: 1-25 | 26-50 | 51-75 | 76-83 |